Dexlansoprazole Capsules and Insulin Degludec (U-100) Vials
Determining the interaction of Dexlansoprazole Capsules and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexlansoprazole
Brand name: Dexilant, Kapidex
Synonyms: Dexlansoprazole
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexlansoprazole Capsules-Insulin Degludec (U-200) Prefilled Pens
- Dexlansoprazole Capsules-Insulin degludec and liraglutide
- Dexlansoprazole Capsules-Insulin degludec and liraglutide Subcutaneous
- Dexlansoprazole Capsules-Insulin degludec Subcutaneous
- Dexlansoprazole Capsules-Insulin detemir
- Dexlansoprazole Capsules-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Dexmedetomidine
- Insulin Degludec (U-100) Vials-Dexmedetomidine Hydrochloride
- Insulin Degludec (U-100) Vials-Dexmedetomidine Hydrochloride Injection
- Insulin Degludec (U-100) Vials-Dexmedetomidine hydrochloride Injection, Concentrate
- Insulin Degludec (U-100) Vials-Dexmethylphenidate
- Insulin Degludec (U-100) Vials-Dexmethylphenidate ER Capsule